In elderly participants with episodic TTH, migraine, CeH, or unclassifiable headaches, no significant differences are described in PPT in the neck region (bilaterally over the articular pillars of the cervical segment C2 3) [23].
John Tukey recommended that for disease mapping, significant differences be described as "unusual occurrences".
In the results section, a significant difference was described between the drug and control groups related to "in flight performance change".
Clusters showing significant between-group differences were described in terms of the Automated Anatomical Labelling (AAL) template image (where voxels/region > 20) (Tzourio-Mazoyer et al., 2002).
Only the assays in which significant differences were observed are described below (for descriptions of other assays see Supplementary Methods S1).
Significant differences were calculated as described before.
No significant differences were found for parameters describing exercise performance (peakVO2 and VO2AT), ventilation on exercise (maximal VE, VE/MVV) as well as ventilatory efficiency (VE vs. VCO2 slope) (see Table 1, 2 and Figures 1, 2, 3).
No significant differences were detected between the above described reticulation groups in observed heterozygosity (p = 0.67), or genetic diversity (p = 0.44) or Fst (p = 0.45).
By contrast and as described above, significant differences were observed for sense read abundance for all of the hvu-MIR399 genes and for the hvu-MIR827 gene between P-deficient and P-sufficient barley (Additional file 12: Table S11).
The effects of oxidative stress were checked at different stages of the experiment as previously described, and no significant differences were found between the four experimental groups and the blank control group until 66th day.
